Khaled Aljenaee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Khaled Aljenaee has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Sulaiman Hajji
Sulaiman Hajji, Endocrinologist, Adan Hospital, Ministry of Health, Kuwait
3 shared publications- Khalid Adnan Shamiyah
Royal College of Surgeons in Ireland-Medical University of Bahrain, Busaiteen, Bahrain
2 shared publications - Khawla Fuad Ali
Department of Medicine, Royal College of Surgeons in Ireland Medical University of Bahrain, Adliya, Bahrain
2 shared publications - Nitya Kumar
Department of Medicine, Royal College of Surgeons in Ireland - Medical University of Bahrain (RCSI-MUB, Building No. 2441, Road 2835, Busaiteen- 228, Bahrain
2 shared publications - Simon Whitebridge
Royal College of Surgeons in Ireland-Medical University of Bahrain, Busaiteen, Bahrain
2 shared publications - Stephen Lawrence Atkin
Royal College of Surgeons in Ireland, Busaiteen, Bahrain
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2026 (1)
Androgen‐Secreting Thecoma Fibroma Mimicking PCOS—A Diagnostic Challenge
Background: Ovarian fibrothecomas are uncommon benign sex cord‐stromal tumors, accounting for ~3.3% of ovarian tumors. They are usually hormonally inactive or estrogen‐producing; androgen secretion is uncommon. Because hyperandrogenism is frequently attributed to polycystic ovary syndrome (PCOS), an androgen‐secreting ovarian tumor may be overlooked when symptoms are progressive but virilization is absent. Case Report: A 42‐year‐old woman developed new‐onset hirsutism, acne, menstrual irregularity, and later scalp hair loss. She was initially diagnosed with PCOS after being reported with biochemical hyperandrogenism and polycystic ovarian morphology on ultrasound (US); the original testosterone value was unavailable. Following transient symptomatic improvement with a combined oral contraceptive pill (COCP), her symptoms recurred and progressed. Repeat evaluation showed a total testosterone level of 5.83 nmol/L and dehydroepiandrosterone sulfate (DHEAS) of 14 µmol/L. CT demonstrated a 5.1 × 4.2 × 4.0 cm mass adjacent to the right ovary with normal adrenal glands. Right oophorectomy was performed, and histopathology confirmed a fibrothecoma with focal luteinization. Three months after surgery, acne and hirsutism improved, and total testosterone decreased to 0.50 nmol/L. Conclusions: Progressive or newly developed hyperandrogenism should not be attributed to PCOS solely on the basis of polycystic ovarian morphology. The tempo of symptoms, biochemical findings, and clinical context should guide evaluation for alternative ovarian or adrenal causes. This case illustrates an uncommon PCOS mimic and the importance of reassessing the diagnosis when the clinical course is atypical.
- 1 January 2026
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2026 (1)
Open AccessAndrogen‐Secreting Thecoma Fibroma Mimicking PCOS—A Diagnostic Challenge
Background: Ovarian fibrothecomas are uncommon benign sex cord‐stromal tumors, accounting for ~3.3% of ovarian tumors. They are usually hormonally inactive or estrogen‐producing; androgen secretion is uncommon. Because hyperandrogenism is frequently attributed to polycystic ovary syndrome (PCOS), an androgen‐secreting ovarian tumor may be overlooked when symptoms are progressive but virilization is absent. Case Report: A 42‐year‐old woman developed new‐onset hirsutism, acne, menstrual irregularity, and later scalp hair loss. She was initially diagnosed with PCOS after being reported with biochemical hyperandrogenism and polycystic ovarian morphology on ultrasound (US); the original testosterone value was unavailable. Following transient symptomatic improvement with a combined oral contraceptive pill (COCP), her symptoms recurred and progressed. Repeat evaluation showed a total testosterone level of 5.83 nmol/L and dehydroepiandrosterone sulfate (DHEAS) of 14 µmol/L. CT demonstrated a 5.1 × 4.2 × 4.0 cm mass adjacent to the right ovary with normal adrenal glands. Right oophorectomy was performed, and histopathology confirmed a fibrothecoma with focal luteinization. Three months after surgery, acne and hirsutism improved, and total testosterone decreased to 0.50 nmol/L. Conclusions: Progressive or newly developed hyperandrogenism should not be attributed to PCOS solely on the basis of polycystic ovarian morphology. The tempo of symptoms, biochemical findings, and clinical context should guide evaluation for alternative ovarian or adrenal causes. This case illustrates an uncommon PCOS mimic and the importance of reassessing the diagnosis when the clinical course is atypical.
- Open Access
- 1 July 2024
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2024 (3)
Amenorrhea as a presentation of Cushing’s syndrome
Summary: Menstrual cycle abnormalities are common in premenopausal females with Cushing’s syndrome, although the underlying mechanism is poorly understood. Signs and symptoms found in Cushing’s syndrome overlap with polycystic ovarian syndrome (PCOS). The patient is a 33-year-old female previously diagnosed by a gynecologist with PCOS and treated with oral contraceptive pills (OCPs) for 2 years. She then discontinued her OCPs without consulting a clinician, resulting in amenorrhea for 6 months, for which she presented. She also had symptoms of depression and anxiety but had no other signs and symptoms of Cushing’s syndrome, except a plethoric face. Initial lab work showed evidence of central hypogonadism (low luteinizing hormone, follicle-stimulating hormone, and estrogen), so a complete anterior pituitary hormone workup was done. Her thyroid-stimulating hormone was also low with a low free T4 level. Prolactin level was normal, but surprisingly, her AM cortisol level was high. The Cushing’s syndrome workup revealed non-suppressed cortisol after a 1 mg dexamethasone suppression test and positive 24-h urine cortisol with suppressed adrenocorticotrophic hormone. A CT scan of her adrenal glands revealed a left adrenal adenoma. She underwent a left adrenalectomy, after which her menstrual cycles became regular again, and pituitary function has recovered. Learning points: In Cushing's syndrome, female patients can have menstrual abnormalities due to the high cortisol levels, which can affect gonadotrophin levels. We encourage clinicians to include Cushing's syndrome in the differential diagnosis of patients with central hypogonadism.
- 1 July 2024
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2024 (3)
Open AccessAmenorrhea as a presentation of Cushing’s syndrome
Summary: Menstrual cycle abnormalities are common in premenopausal females with Cushing’s syndrome, although the underlying mechanism is poorly understood. Signs and symptoms found in Cushing’s syndrome overlap with polycystic ovarian syndrome (PCOS). The patient is a 33-year-old female previously diagnosed by a gynecologist with PCOS and treated with oral contraceptive pills (OCPs) for 2 years. She then discontinued her OCPs without consulting a clinician, resulting in amenorrhea for 6 months, for which she presented. She also had symptoms of depression and anxiety but had no other signs and symptoms of Cushing’s syndrome, except a plethoric face. Initial lab work showed evidence of central hypogonadism (low luteinizing hormone, follicle-stimulating hormone, and estrogen), so a complete anterior pituitary hormone workup was done. Her thyroid-stimulating hormone was also low with a low free T4 level. Prolactin level was normal, but surprisingly, her AM cortisol level was high. The Cushing’s syndrome workup revealed non-suppressed cortisol after a 1 mg dexamethasone suppression test and positive 24-h urine cortisol with suppressed adrenocorticotrophic hormone. A CT scan of her adrenal glands revealed a left adrenal adenoma. She underwent a left adrenalectomy, after which her menstrual cycles became regular again, and pituitary function has recovered. Learning points: In Cushing's syndrome, female patients can have menstrual abnormalities due to the high cortisol levels, which can affect gonadotrophin levels. We encourage clinicians to include Cushing's syndrome in the differential diagnosis of patients with central hypogonadism.
- Open Access
- 1 January 2024
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2024 (1)
Clinically functioning gonadotropin-secreting pituitary adenoma
Summary: Gonadotroph adenomas are the most common type of nonfunctional pituitary adenomas. However, functioning gonadotroph adenomas causing clinical manifestations are rare. We present the case of a 42-year-old man with an incidental finding of a pituitary gland mass. A pituitary MRI revealed a 3 cm macroadenoma, and laboratory investigations revealed elevated follicle-stimulating hormone (FSH) and total testosterone levels. A diagnosis of functioning FSH-secreting pituitary adenoma was considered, with possible concomitant luteinizing hormone secretion, given the elevated testosterone, prompting further evaluation. Testicular ultrasound showed bilaterally enlarged testicles, and visual field testing revealed a monocular superior temporal defect. Transsphenoidal resection of pituitary adenoma was the treatment of choice. Histopathology assessment confirmed the diagnosis of gonadotroph-secreting adenoma, with positive staining for FSH. Within the 12-week postoperative period, FSH and testosterone levels normalized, and the patient experienced significant improvement in vision, along with the resolution of macroorchidism. While functional gonadotroph adenomas are rare, patients can present with a wide range of symptoms that are often unnoticeable due to their slow development. Careful evaluation can help guide multidisciplinary management to achieve full remission. Learning points: Endocrine evaluation is indicated in all cases of pituitary incidentalomas to determine functional status. Clinically functioning gonadotroph adenomas, while rare, pose a diagnostic challenge and require careful clinical evaluation. Transsphenoidal surgery is the mainstay of treatment of functioning gonadotroph adenomas, with the involvement of a multidisciplinary team to achieve desirable outcomes.
- 1 January 2024
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2024 (1)
Open AccessClinically functioning gonadotropin-secreting pituitary adenoma
Summary: Gonadotroph adenomas are the most common type of nonfunctional pituitary adenomas. However, functioning gonadotroph adenomas causing clinical manifestations are rare. We present the case of a 42-year-old man with an incidental finding of a pituitary gland mass. A pituitary MRI revealed a 3 cm macroadenoma, and laboratory investigations revealed elevated follicle-stimulating hormone (FSH) and total testosterone levels. A diagnosis of functioning FSH-secreting pituitary adenoma was considered, with possible concomitant luteinizing hormone secretion, given the elevated testosterone, prompting further evaluation. Testicular ultrasound showed bilaterally enlarged testicles, and visual field testing revealed a monocular superior temporal defect. Transsphenoidal resection of pituitary adenoma was the treatment of choice. Histopathology assessment confirmed the diagnosis of gonadotroph-secreting adenoma, with positive staining for FSH. Within the 12-week postoperative period, FSH and testosterone levels normalized, and the patient experienced significant improvement in vision, along with the resolution of macroorchidism. While functional gonadotroph adenomas are rare, patients can present with a wide range of symptoms that are often unnoticeable due to their slow development. Careful evaluation can help guide multidisciplinary management to achieve full remission. Learning points: Endocrine evaluation is indicated in all cases of pituitary incidentalomas to determine functional status. Clinically functioning gonadotroph adenomas, while rare, pose a diagnostic challenge and require careful clinical evaluation. Transsphenoidal surgery is the mainstay of treatment of functioning gonadotroph adenomas, with the involvement of a multidisciplinary team to achieve desirable outcomes.
- Open Access
- 1 July 2023
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2023 (3)
Sertoliform endometrioid carcinoma of the right ovary
Summary: Endometrioid carcinomas of the ovary are a subtype of epithelial ovarian tumors, with sertoliform endometrioid carcinomas being a rare variant. We report a case of a previously healthy premenopausal woman presenting with androgenic symptoms in the form of hirsutism and male pattern alopecia. On further testing, she was found to have high levels of luteinizing hormone and total testosterone levels, and imaging revealed a large pelvic abdominal mass in the right ovary. She underwent total hysterectomy with bilateral salpingo-oophorectomy. Microscopy and histopathology confirmed the diagnosis of sertoliform endometrioid carcinoma. Her symptoms improved significantly on follow-up. Androgenic tumors might not be common in premenopausal women; however, it is important to maintain a high level of suspicion in patients presenting with virilizing symptoms especially of rapid progression. Learning points: Our 47-year-old patient presented with virilizing symptoms that were rapidly progressing, which raises the suspicion of an underlying androgen secreting neoplasm. Sertoliform endometrioid carcinoma (SEC) is an extremely rare variant of endometrioid carcinomas and tend to present at an earlier stage as compared to most endometrioid carcinomas of the ovary. Recognition of SEC in virilizing patients is important as it is a well-differentiated, low-grade malignancy with a good prognosis when confined to the ovary.
- 1 July 2023
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2023 (3)
Open AccessSertoliform endometrioid carcinoma of the right ovary
Summary: Endometrioid carcinomas of the ovary are a subtype of epithelial ovarian tumors, with sertoliform endometrioid carcinomas being a rare variant. We report a case of a previously healthy premenopausal woman presenting with androgenic symptoms in the form of hirsutism and male pattern alopecia. On further testing, she was found to have high levels of luteinizing hormone and total testosterone levels, and imaging revealed a large pelvic abdominal mass in the right ovary. She underwent total hysterectomy with bilateral salpingo-oophorectomy. Microscopy and histopathology confirmed the diagnosis of sertoliform endometrioid carcinoma. Her symptoms improved significantly on follow-up. Androgenic tumors might not be common in premenopausal women; however, it is important to maintain a high level of suspicion in patients presenting with virilizing symptoms especially of rapid progression. Learning points: Our 47-year-old patient presented with virilizing symptoms that were rapidly progressing, which raises the suspicion of an underlying androgen secreting neoplasm. Sertoliform endometrioid carcinoma (SEC) is an extremely rare variant of endometrioid carcinomas and tend to present at an earlier stage as compared to most endometrioid carcinomas of the ovary. Recognition of SEC in virilizing patients is important as it is a well-differentiated, low-grade malignancy with a good prognosis when confined to the ovary.
- Open Access
- 2 February 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e34074
The Impact of COVID-19 on the Prevalence and Perception of Telehealth Use in the Middle East and North Africa Region: Survey Study
Background: Due to the COVID-19 pandemic, telehealth has become a safer way to access health care. The telehealth industry has rapidly expanded over the last decade as a modality to provide patient-centered care. However, the prevalence of its use and patient acceptability remains unclear in the Middle East and North Africa (MENA) region. Objective: The primary aim was to assess the prevalence of telehealth use before and during the pandemic by using social media (Instagram) as an online platform for survey administration across different countries simultaneously. Our secondary aim was to assess the perceptions regarding telehealth among those using it. Methods: An Instagram account that reaches 130,000 subjects daily was used to administer a questionnaire that assessed the current prevalence of telehealth use and public attitudes and acceptability toward this modality of health care delivery during the COVID-19 pandemic. Results: A total of 1524 respondents participated in the survey (n=1356, 89% female; median age 31 years), of whom 97.6% (n=1487) lived in the Gulf Cooperation Council (GCC) region. Prior to COVID-19, 1350 (88.6%) had no exposure to telehealth. Following the COVID-19 pandemic, telehealth use increased by 251% to a total of 611 users (40% of all users). About 89% (571/640) of telehealth users used virtual visits for specialist visits. Of the 642 participants who reported using telehealth, 236 (36.8%) reported their willingness to continue using telehealth, 241 (37.5%) were unsure, and 164 (25.5%) did not wish to continue to use telehealth after the COVID-19 pandemic. An inverse trend, although not statistically significant, was seen between willingness to continue telehealth use and the number of medical comorbidities (odds ratio [OR] 0.81, 95% CI 0.64-1.03; P=.09). Compared to the respondents who chose only messaging as the modality they used for telehealth, respondents who chose both messaging and phone calls were significantly less likely to recommend telehealth (OR 0.42, 95% CI 0.22-0.80; P=.009). Overall, there was general satisfaction with telehealth, and respondents reported that telehealth consultations made them feel safer and saved both time and money. Conclusions: Telehealth use increased dramatically after the COVID-19 pandemic, and telehealth was found to be acceptable among some young adult groups on Instagram. However, further innovation is warranted to increase acceptability and willingness to continue telehealth use for the delivery of health care.
- 2 February 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e34074
Open AccessThe Impact of COVID-19 on the Prevalence and Perception of Telehealth Use in the Middle East and North Africa Region: Survey Study
Background: Due to the COVID-19 pandemic, telehealth has become a safer way to access health care. The telehealth industry has rapidly expanded over the last decade as a modality to provide patient-centered care. However, the prevalence of its use and patient acceptability remains unclear in the Middle East and North Africa (MENA) region. Objective: The primary aim was to assess the prevalence of telehealth use before and during the pandemic by using social media (Instagram) as an online platform for survey administration across different countries simultaneously. Our secondary aim was to assess the perceptions regarding telehealth among those using it. Methods: An Instagram account that reaches 130,000 subjects daily was used to administer a questionnaire that assessed the current prevalence of telehealth use and public attitudes and acceptability toward this modality of health care delivery during the COVID-19 pandemic. Results: A total of 1524 respondents participated in the survey (n=1356, 89% female; median age 31 years), of whom 97.6% (n=1487) lived in the Gulf Cooperation Council (GCC) region. Prior to COVID-19, 1350 (88.6%) had no exposure to telehealth. Following the COVID-19 pandemic, telehealth use increased by 251% to a total of 611 users (40% of all users). About 89% (571/640) of telehealth users used virtual visits for specialist visits. Of the 642 participants who reported using telehealth, 236 (36.8%) reported their willingness to continue using telehealth, 241 (37.5%) were unsure, and 164 (25.5%) did not wish to continue to use telehealth after the COVID-19 pandemic. An inverse trend, although not statistically significant, was seen between willingness to continue telehealth use and the number of medical comorbidities (odds ratio [OR] 0.81, 95% CI 0.64-1.03; P=.09). Compared to the respondents who chose only messaging as the modality they used for telehealth, respondents who chose both messaging and phone calls were significantly less likely to recommend telehealth (OR 0.42, 95% CI 0.22-0.80; P=.009). Overall, there was general satisfaction with telehealth, and respondents reported that telehealth consultations made them feel safer and saved both time and money. Conclusions: Telehealth use increased dramatically after the COVID-19 pandemic, and telehealth was found to be acceptable among some young adult groups on Instagram. However, further innovation is warranted to increase acceptability and willingness to continue telehealth use for the delivery of health care.
- Open Access
- 6 October 2021
- Published by JMIR Publications Inc. in JMIR Preprints
The Impact of COVID-19 on the Prevalence and Perception of Telehealth Utilization. (Preprint)
BACKGROUND Due to the COVID-19 pandemic, telehealth has emerged as a safer way to access healthcare. The telehealth industry has been rapidly expanding over the last decade as a modality to provide patient-centered care. However, the prevalence of its use and patient acceptability remains unclear in the Middle East and North Africa (MENA) region. OBJECTIVE The primary aim was to assess the prevalence of telehealth use before and during the pandemic by utilizing social media (Instagram) as an online platform for survey administration across different countries simultaneously. Our secondary aim was to assess the perceptions regarding telehealth usage amongst those utilizing it. METHODS An online social media platform (Instagram) that reaches 130,000 subjects daily, was used to administer a questionnaire that assessed the current prevalence of telehealth use and public attitudes and acceptability towards this modality of healthcare delivery during the COVID-19 pandemic. RESULTS 1524 respondents participated in the survey (females 89.3%; age range 25-38) of whom 91.2% lived in the GCC. Prior to COVID-19, 1440 (88%) had no exposure to telehealth. Following the covid-19 pandemic telehealth usage increased by 237% to a total of 644 users (40%) (follow-up consultations (n=410, 47%); first-time consultations (n=348, 40%)) that was associated with older age (p=0.001), having one or more comorbidities (p=0.001), taking one or more pills (p=0.001), living in the GCC (p=0.003). Those who reported using telehealth (n=679), 247 (36.4%) reported their willingness to continue using telehealth, 254 (37.4%) were unsure and 178 (26.2%) did not wish to continue to use telehealth after the COVID19 pandemic. An inverse relationship between telehealth usage and the increasing number of medical comorbidities was shown (OR= 0.76, p= 0.023). Respondents using messaging or video telehealth usage were more likely recommend virtual visits than those who used audio calls (OR= 0.49, p= 0.024). Overall, there was general satisfaction with telehealth usage and respondents found telehealth to be equally effective to in-person visits. CONCLUSIONS Telehealth usage increased dramatically and was found to be acceptable though less so if there were other comorbidities; however, further innovation to increase telehealth acceptability is needed if this is to have greater future utility in healthcare delivery.
- 6 October 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Impact of COVID-19 on the Prevalence and Perception of Telehealth Utilization. (Preprint)
BACKGROUND Due to the COVID-19 pandemic, telehealth has emerged as a safer way to access healthcare. The telehealth industry has been rapidly expanding over the last decade as a modality to provide patient-centered care. However, the prevalence of its use and patient acceptability remains unclear in the Middle East and North Africa (MENA) region. OBJECTIVE The primary aim was to assess the prevalence of telehealth use before and during the pandemic by utilizing social media (Instagram) as an online platform for survey administration across different countries simultaneously. Our secondary aim was to assess the perceptions regarding telehealth usage amongst those utilizing it. METHODS An online social media platform (Instagram) that reaches 130,000 subjects daily, was used to administer a questionnaire that assessed the current prevalence of telehealth use and public attitudes and acceptability towards this modality of healthcare delivery during the COVID-19 pandemic. RESULTS 1524 respondents participated in the survey (females 89.3%; age range 25-38) of whom 91.2% lived in the GCC. Prior to COVID-19, 1440 (88%) had no exposure to telehealth. Following the covid-19 pandemic telehealth usage increased by 237% to a total of 644 users (40%) (follow-up consultations (n=410, 47%); first-time consultations (n=348, 40%)) that was associated with older age (p=0.001), having one or more comorbidities (p=0.001), taking one or more pills (p=0.001), living in the GCC (p=0.003). Those who reported using telehealth (n=679), 247 (36.4%) reported their willingness to continue using telehealth, 254 (37.4%) were unsure and 178 (26.2%) did not wish to continue to use telehealth after the COVID19 pandemic. An inverse relationship between telehealth usage and the increasing number of medical comorbidities was shown (OR= 0.76, p= 0.023). Respondents using messaging or video telehealth usage were more likely recommend virtual visits than those who used audio calls (OR= 0.49, p= 0.024). Overall, there was general satisfaction with telehealth usage and respondents found telehealth to be equally effective to in-person visits. CONCLUSIONS Telehealth usage increased dramatically and was found to be acceptable though less so if there were other comorbidities; however, further innovation to increase telehealth acceptability is needed if this is to have greater future utility in healthcare delivery.